Astellas Pharma Inc. (ALPMY)
OTCMKTS
· Delayed Price · Currency is USD
9.48
-0.07 (-0.73%)
Jan 22, 2025, 11:52 AM EST
Astellas Pharma Employees
Astellas Pharma had 14,754 employees as of March 31, 2024. The number of employees increased by 270 or 1.86% compared to the previous year.
Employees
14,754
Change (1Y)
270
Growth (1Y)
1.86%
Revenue / Employee
$838,407
Profits / Employee
$25,900
Market Cap
17.12B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
Astellas Pharma News
- 27 days ago - Pharma Giant Warns Pills Critical For Organ Transplant Patients' to Survive May Be Completely Empty in Urgent Recall - IBTimes
- 27 days ago - Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders - Business Wire
- 4 weeks ago - Sangamo spikes on Astellas licensing deal for gene therapy tech - Seeking Alpha
- 6 weeks ago - Astellas and Dr. Jen Ashton launch "Cooler Moments" to Spotlight Menopausal Hot Flashes and Empower Women to Advocate for Themselves - PRNewsWire
- 2 months ago - Astellas Announces Desert Oasis Healthcare as First Health System to Implement DIGITIVA™ for Heart Failure Management - PRNewsWire
- 2 months ago - Astellas Pharma Inc. (ALPMF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Astellas: Can The Gastric Cancer Approval Be The Inflection Point? - Seeking Alpha
- 3 months ago - Astellas Pharma reports H1 results - Seeking Alpha